Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
16
NCT03408132
Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 2, 2018
Completion: Oct 28, 2019
NCT03415594
Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support
Start: May 8, 2018
Completion: Nov 21, 2019
NCT03417765
Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas
Start: Sep 1, 2018
Completion: Mar 31, 2019